Long-term clinical value and outcome of riociguat in chronic thromboembolic pulmonary hypertension
Background: To improve clinical outcome, patients with inoperable and residual chronic thromboembolic pulmonary hypertension (CTEPH) can be treated with riociguat. The aim of this study is to explore long-term outcomes and to compare our ‘real world’ data with previous research. Methods: We included...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-03-01
|
Series: | International Journal of Cardiology: Heart & Vasculature |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352906719300144 |